Israel authorises Moderna’s COVID-19 vaccine for use

pharmafile | January 5, 2021 | News story | Manufacturing and Production COVID-19, Moderna, Vaccine 

Moderna has announced that Israel’s Ministry of Health (MOH) has authorised the use of its COVID-19 vaccine.

Israel has secured six million doses of the company’s vaccine, and the first deliveries are expected to begin soon. It is the third country to authorise the Moderna jab, following the US and Canada in December.

Additional authorisations are currently under review in the EU, Singapore, Switzerland, and the United Kingdom.

The decision from Israel’s MOH is based on a rolling submission of data and the totality of scientific evidence shared by the company, including a data analysis from the pivotal Phase III clinical study, which was announced on November 30.

The news comes as Israel leads the global vaccine race, having vaccinated one million of its people. Its vaccination rate of 11.55 doses per 100 people is currently the highest in the world.

Stéphane Bancel, Chief Executive Officer of Moderna, said: “Today’s authorisation is a landmark moment in our company’s history and in the global fight against COVID-19.

“I want to thank the Ministry of Health of Israel for their efforts, as their team have worked tirelessly alongside ours to ensure a timely authorisation of this vaccine. We hope to continue to see authorisations in additional markets in the coming days, weeks and months.”

Darcy Jimenez

Related Content


GSK’s RSV vaccine approved in EU for older adults

GSK has announced that the European Commission (EC) has authorised Arexvy, the company’s respiratory syncytial …

FDA approves Pfizer’s RSV vaccine for older adults

Global pharmaceutical company Pfizer has announced that the US Food and Drug Administration (FDA) has …

FDA approves first oral antiviral to treat adult patients with COVID-19

The US Food and Drug Administration (FDA) has announced that it has approved the oral …

Latest content